Cervical cancer screening: Too many are left unprotected

Sep 19, 2007

The decline in cervical cancer is a success story of cancer research. Although there are reasons to be optimistic about even further decreases in cervical cancer incidence, there still remain some women who are not screened. A meta-analysis by Spence and colleagues published in the August-September 2007 issue of Preventive Medicine shows that undergoing Pap smears irregularly or never was the primary explanation for the development of invasive cervical cancer, followed by false negative tests and poor follow-up of abnormal results.

Papanicolaou and Traut first reported the usefulness of the Papanicolaou smear (''Pap test") for detecting neoplastic cervical cells in 1943. A smear of cells of the uterine cervix indicating the progression of the cancer's growing malignity provided a powerful screening tool that became rapidly used after WWII without its efficacy being evaluated in a randomized control trial.

In the United States, the Pap test is credited with having halved the annual cervical cancer incidence rate (from 17.2 to 8.0 per 100,000) and mortality rate (from 6.2 to 2.9) from 1973 to 1999. In 2000, 83% of U.S. women age 18 and older who had not had a hysterectomy reported having had a Pap test within the past 3 years. The recent discovery of a vaccine against human papillomavirus (HPV), the main cause of cervical cancer, opens the way to the primary prevention of the disease.

The natural history of cervical cancer progression combined with the availability of an HPV vaccine and an effective screening test indicate that eradication of the disease is a plausible objective. To reach that goal, however, it is important not to give up on the minority of women who do not fully benefit from available prevention methods and unfortunately fail to be reached by health promotion messages.

Dr. Eduardo Franco, the study’s principal investigator, commented on the findings: “Cervical cancer is a sentinel disease of inequity. The socio-economic disparity already seen with availability of screening could aggravate if vaccination fails to reach the daughters of women at greatest risk. Like mothers, like daughters; the latter unvaccinated and unprotected by screening will eventually contribute to the sad reality of cervical cancer statistics in the future. The solution is to adopt vaccination and screening as universal strategies, with the latter modified to make cost-effective use of limited resources.”

Source: Elsevier

Explore further: Key find for early bladder cancer treatment

add to favorites email to friend print save as pdf

Related Stories

HPV test beats Pap for cervical cancer screening

May 18, 2011

Two big studies suggest possible new ways to screen healthy people for cervical or prostate cancers, but a third disappointed those hoping for a way to detect early signs of deadly ovarian tumors.

Many cancers detected late in US: study

Nov 24, 2010

Almost half of cervical and colorectal cancers in the United States are diagnosed in the late stages of the disease when treatment is unlikely to help, a US government survey said Wednesday.

Recommended for you

Key find for early bladder cancer treatment

1 hour ago

Aggressive forms of bladder cancer involve the protein PODXL – a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.

Cold plasma successful against brain cancer cells

1 hour ago

For the first time, physicists from the Max Planck Institute for Extraterrestrial Physics (MPE), biologists and physicians demonstrated the synergistic effect of cold atmospheric plasma - a partly ionized ...

User comments : 0

More news stories

Chemists find new compounds to curb staph infection

(Phys.org) —In an age when microbial pathogens are growing increasingly resistant to the conventional antibiotics used to tamp down infection, a team of Wisconsin scientists has synthesized a potent new ...

Engineers pioneer flat spray-on optical lens

A University of British Columbia engineer and a team of U.S. researchers have made a breakthrough utilizing spray-on technology that could revolutionize the way optical lenses are made and used.